CV · TickerCove

CVCapsoVision, Inc.Healthcare · Medical - Devicesas of 2026-09-16

Horizon

Issued 2026-09-16 at $5.99 · now $5.99 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, CV has typically landed between $4.45 and $10.03 — a range of −25.7% to +67.4% from the issuance price $5.99.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

283 overlapping 1 month windows · 2025-07-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($5.99) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$5.99 · 15% of range

$4.46 low$14.42 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

+2.6%

typical move · IQR 25.7%

−25.7%worst (p90)+67.4%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where CV has typically landed a month from the 2026-09-16 close of $5.99 — the range is history, not a prediction.

now $5.99 (+0.0%)
typical $6.14 (+2.6%)
middle 50% $5.37–$6.91
90% range $4.45–$10.03

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 283 windows spanning 2025-07-02 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2025-12-24	−61.9%	−61.9%	+0.0%
2025-12-11	−60.6%	−60.6%	+0.0%
2025-12-26	−59.6%	−59.6%	+0.0%
3 best
2025-11-11	+164.6%	−6.1%	+164.6%
2025-11-24	+163.4%	+0.0%	+173.6%
2025-11-19	+148.2%	−1.9%	+170.5%

283 overlapping windows · 2025-07-02 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~2 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

−53.0%

n=1

Feb

100%

+9.4%

n=1

Mar

100%

+32.8%

n=1

Apr

−2.9%

n=1

May

−4.2%

n=1

Jun

100%

+11.8%

n=1

Jul

−13.2%

n=1

Aug

−7.2%

n=2

Sep

100%

+15.8%

n=2

Oct

100%

+0.8%

n=1

Nov

100%

+14.5%

n=1

Dec

100%

+91.2%

n=1

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-07-17	HARARI ELIYAHOU ET AL	tenPercentOwner	Purchase	61,068 @ $6.73	$411K	+1.9% of holding	−7.8%	not yet — horizon still open	3,343,119	Form 4 · filed 4 days after the trade
2026-07-08	HARARI ELIYAHOU ET AL	tenPercentOwner	Purchase	81,300 @ $6.09	$495K	+2.5% of holding	+9.5%	not yet — horizon still open	3,282,051	Form 4 · filed 2 days after the trade
2026-06-26	HARARI ELIYAHOU ET AL	tenPercentOwner	Purchase	13,850 @ $7.35	$102K	+0.4% of holding	−13.6%	not yet — horizon still open	3,200,751	Form 4 · filed 11 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

85 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-07-01	Shields David Stanley	director	Award / grant	1,710	1,710	Form 4
2026-06-30	Kuo Hui Ying	director	Option exercise	2,022	15,263	Form 4
2026-06-30	GOUW JULIA S	director	Option exercise	2,022	4,909	Form 4
2026-06-30	Tsai Chen Lung	director	Option exercise	2,022	4,929	Form 4
2026-06-30	Imperial Joanne Carol	director	Option exercise	2,022	3,709	Form 4
2026-06-30	Harari Michele	director	Option exercise	2,022	61,065	Form 4
2026-06-30	King Wen-Herng Henry	director	Option exercise	2,022	25,619	Form 4
2026-06-30	GOUW JULIA S	director	Option exercise	2,022	2,023	Form 4
2026-06-30	Imperial Joanne Carol	director	Option exercise	2,022	2,023	Form 4
2026-06-30	Kuo Hui Ying	director	Option exercise	2,022	2,023	Form 4
2026-06-30	Tsai Chen Lung	director	Option exercise	2,022	2,023	Form 4
2026-06-30	Harari Michele	director	Option exercise	2,022	2,023	Form 4
2026-06-30	King Wen-Herng Henry	director	Option exercise	2,022	2,023	Form 4
2026-06-01	Wang Kang-Huai	director	Award / grant	358,344	629,304	Form 4
2026-06-01	Atkinson Douglas Patrick	officer	Award / grant	158,078	176,847	Form 4
2026-06-01	Garcia David Michael	officer	Award / grant	92,212	257,212	Form 4
2026-05-05	Atkinson Douglas Patrick	officer	Option exercise	34,786	107,357	Form 4
2026-05-05	Atkinson Douglas Patrick	officer	Option exercise	34,786	18,769	Form 4
2026-05-04	Atkinson Douglas Patrick	officer	Option exercise	30,030	66,066	Form 4
2026-05-04	Atkinson Douglas Patrick	officer	Option exercise	36,036	36,036	Form 4
2026-05-04	Atkinson Douglas Patrick	officer	Option exercise	6,505	72,571	Form 4
2026-05-04	Atkinson Douglas Patrick	officer	Option exercise	36,036	0	Form 4
2026-05-04	Atkinson Douglas Patrick	officer	Option exercise	6,505	53,555	Form 4
2026-05-04	Atkinson Douglas Patrick	officer	Option exercise	30,030	0	Form 4
2026-03-19	King Wen-Herng Henry	director	Award / grant	4,045	4,045	Form 4
2026-03-19	Imperial Joanne Carol	director	Award / grant	4,045	4,045	Form 4
2026-03-19	Harari Michele	director	Award / grant	4,045	4,045	Form 4
2026-03-19	GOUW JULIA S	director	Award / grant	4,045	4,045	Form 4
2026-03-19	Kuo Hui Ying	director	Award / grant	4,045	4,045	Form 4
2026-03-19	Tsai Chen Lung	director	Award / grant	4,045	4,045	Form 4
2025-12-31	Kuo Hui Ying	director	Option exercise	2,887	13,241	Form 4
2025-12-31	King Wen-Herng Henry	director	Option exercise	2,887	23,597	Form 4
2025-12-31	GOUW JULIA S	director	Option exercise	2,887	2,887	Form 4
2025-12-31	Tsai Chen Lung	director	Option exercise	2,887	2,887	Form 4
2025-12-31	Harari Michele	director	Option exercise	2,887	59,043	Form 4
2025-12-31	Imperial Joanne Carol	director	Option exercise	2,887	2,887	Form 4
2025-12-31	GOUW JULIA S	director	Option exercise	2,887	0	Form 4
2025-12-31	King Wen-Herng Henry	director	Option exercise	2,887	0	Form 4
2025-12-31	Tsai Chen Lung	director	Option exercise	2,887	0	Form 4
2025-12-31	Harari Michele	director	Option exercise	2,887	0	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i